{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:54:50Z","timestamp":1777474490942,"version":"3.51.4"},"reference-count":30,"publisher":"Bentham Science Publishers Ltd.","issue":"5","funder":[{"DOI":"10.13039\/100008605","name":"Indian National Science Academy","doi-asserted-by":"publisher","award":["Z. 28015\/252\/2015-HPC(EMR)-AYUSH-C"],"award-info":[{"award-number":["Z. 28015\/252\/2015-HPC(EMR)-AYUSH-C"]}],"id":[{"id":"10.13039\/100008605","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007613","name":"Deanship of Scientific Research at Majmaah University","doi-asserted-by":"publisher","award":["38\/134"],"award-info":[{"award-number":["38\/134"]}],"id":[{"id":"10.13039\/501100007613","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PPL"],"published-print":{"date-parts":[[2019,5,29]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Leishmaniasis is caused by a protozoan parasite, Leishmania. It is common in more than 98 countries throughout the world. Due to insufficient availability of antileishmanial chemotherapeutics, it is an urgent need to search for new molecules which have better efficacy, low toxicity and are available at low cost.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives:<\/jats:title><jats:p>There is a high rate of diabetic cases throughout the world that is why we planned to test the antileishmanial activity of glyburide, an effective sugar lowering drug used for the treatment of diabetes. In this study, glyburide showed a significant decrease in the parasite growth and survival in vitro in a dose-dependent manner.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Anti-leishmanial activity of glyburide was checked by culturing Leishmania donovani promastigotes in the presence of glyburide in a dose and time dependent manner. Docking study against Leishmania donovani-Trypanothione synthetase (LdTrySyn) protein was performed using Autodock Vina tool.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Growth reversibility assay shows that growth of treated parasite was not reversed when transferred to fresh culture media after 7 days. Moreover, docking studies show efficient interactions of glyburide with key residues in the catalytic site of Leishmania donovani- Trypanothione synthetase (LdTrySyn), a very important leishmanial enzyme involved in parasite\u2019s survival by detoxification of Nitric Oxide (NO) species, generated by the mammalian host as a defense molecule. Thus this study proves that the drug-repurposing is a beneficial strategy for identification of new and potent antileishmanial molecules.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>The results suggest that glyburide binds to LdTrySyn and inhibits its activity which further leads to the altered parasite morphology and inhibition of parasite growth. Glyburide may also be used in combination with other anti-leishmanial drugs to potentiate the response of the chemotherapy. Overall this study provides information about combination therapy as well as a single drug treatment for the infected patients suffering from diabetes. This study also provides raw information for further in vivo disease model studies to confirm the hypothesis.<\/jats:p><\/jats:sec>","DOI":"10.2174\/0929866526666190301114012","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T12:03:15Z","timestamp":1551700995000},"page":"371-376","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Repurposing Glyburide as Antileishmanial Agent to Fight Against Leishmaniasis"],"prefix":"10.2174","volume":"26","author":[{"given":"Abdur","family":"Rub","sequence":"first","affiliation":[{"name":"Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Al Majmaah 11952, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal","family":"Shaker","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Al Majmaah 11952, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Kashif","sequence":"additional","affiliation":[{"name":"Infection and Immunity Lab, Department of Biotechnology, Jamia Millia Islamia (A Central University), New Delhi 110025, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohd","family":"Arish","sequence":"additional","affiliation":[{"name":"Infection and Immunity Lab, Department of Biotechnology, Jamia Millia Islamia (A Central University), New Delhi 110025, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul Aziz Bin","family":"Dukhyil","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Al Majmaah 11952, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bader Mohammed","family":"Alshehri","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Al Majmaah 11952, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed A.","family":"Alaidarous","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Al Majmaah 11952, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Banawas","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Al Majmaah 11952, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khwaja","family":"Amir","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, College of Medicine, Majmaah University, Al Majmaah 11952, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"Alvar J.","year":"2012","unstructured":"Alvar J, V\u00e9lez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, de Boer M. Leishmaniasis worldwide and global estimates of its incidence.","journal-title":"PLoS One"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.micinf.2013.06.006","volume":"15","author":"Rub A.","year":"2013","unstructured":"Rub A, Arish M, Husain SA, Ahmed N, Akhter Y. Host-lipidome as a potential target of protozoan parasites.","journal-title":"Microbes Infect"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2174\/1871526516666161230124513","volume":"17","author":"Kashif M.","year":"2017","unstructured":"Kashif M, Manna PP, Akhter Y, Alaidarous M, Rub A. Screening of novel inhibitors against i calcium ion channel to fight leishmaniasis.","journal-title":"Infect Disord Drug Targets"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.ijpara.2007.04.003","volume":"37","author":"Bates P.A.","year":"2007","unstructured":"Bates PA. Transmission of leishmania metacyclic promastigotes by phlebotomine sand flies.","journal-title":"Int J Parasitol"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","volume":"366","author":"Murray H.W.","year":"2005","unstructured":"Murray HW, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis.","journal-title":"Lancet"},{"key":"ref=6","first-page":"10","volume":"3","author":"Akhoundi M.","year":"2016","unstructured":"Akhoundi M, Kuhls K, Cannet A, Vot\u00fdpka J, Marty P, Delaunay P, Sereno D. A Historical overview of the classification, evolution, and dispersion of leishmania parasites and sandflies.","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","volume":"392","author":"Burza S.","year":"2018","unstructured":"Burza S, Croft SL, Boelaert M. Leishmaniasis.","journal-title":"Lancet"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/ni.1705","volume":"10","author":"Rub A.","year":"2009","unstructured":"Rub A, Dey R, Jadhav M, Kamat R, Chakkaramakkil S, Majumdar S, Mukhopadhyaya R, Saha B. Cholesterol depletion associated with leishmania major infection alters macrophage CD40 signalosome composition and effector function.","journal-title":"Nat Immunol"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.biochi.2015.04.005","volume":"113","author":"Arish M.","year":"2015","unstructured":"Arish M, Husein A, Kashif M, Sandhu P, Hasnain SE, Akhter Y, Rub A. Orchestration of membrane receptor signaling by membrane lipids.","journal-title":"Biochimie"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"e0006647","DOI":"10.1371\/journal.pntd.0006647","volume":"12","author":"Arish M.","year":"2018","unstructured":"Arish M, Husein A, Ali R, Tabrez S, Naz F, Ahmad MZ, Rub A. Sphingosine-1-phosphate signaling in infection in macrophages.","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"571242","DOI":"10.4061\/2011\/571242","volume":"2011","author":"Haldar A.K.","year":"2011","unstructured":"Haldar AK, Sen P, Roy S. Use of antimony in the treatment of leishmaniasis: Current status and future directions.","journal-title":"Mol Biol Int"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1056\/NEJMoa021556","volume":"347","author":"Sundar S.","year":"2002","unstructured":"Sundar S, Jha TK, Thakur CP, Engel J, Sindermann H, Fischer C, Junge K, Bryceson A, Berman J. Oral miltefosine for Indian visceral leishmaniasis.","journal-title":"N Engl J Med"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s004300100088","volume":"190","author":"Sundar S.","year":"2001","unstructured":"Sundar S. Treatment of visceral leishmaniasis.","journal-title":"Med Microbiol Immunol"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1017\/S0031182017000993","volume":"145","author":"Charlton R.L.","year":"2018","unstructured":"Charlton RL, Rossi-Bergmann B, Denny PW, Steel PG. Repurposing as a Strategy for the discovery of new anti-leishmanials: The-state-of-the-art.","journal-title":"Parasitology"},{"key":"ref=15","first-page":"967","volume":"23","author":"de Menezes J.","year":"2015","unstructured":"de Menezes J, Guedes C, Petersen A, Fraga D, Veras P. Leishmaniasis treatment: Update of possibilities for drug repurposing.","journal-title":"BioMed Res Int"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1053\/j.semperi.2014.08.012","volume":"38","author":"Ryu R.J.","year":"2014","unstructured":"Ryu RJ, Hays KE, Hebert MF. Gestational diabetes mellitus management with oral hypoglycemic agents.","journal-title":"Semin Perinatol"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0169-409X(02)00174-6","volume":"55","author":"Young A.M.","year":"2003","unstructured":"Young AM, Allen CE, Audus KL. Efflux transporters of the human placenta.","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.placenta.2005.11.012","volume":"27","author":"Gedeon C.","year":"2006","unstructured":"Gedeon C, Behravan J, Koren G, Piquette-Miller M. Transport of glyburide by placental ABC transporters: Implications in fetal drug exposure.","journal-title":"Placenta"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1002\/jcb.26433","volume":"119","author":"Kashif M.","year":"2018","unstructured":"Kashif M, Tabrez S, Husein A, Arish M, Kalaiarasan P, Manna PP, Subbarao N, Akhter Y, Rub A. Identification of novel inhibitors against UDP-galactopyranose mutase to combat leishmaniasis.","journal-title":"J Cell Biochem"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/15216540310001639265","volume":"55","author":"Ascenzi P.","year":"2003","unstructured":"Ascenzi P, Bocedi A, Gradoni L. The anti-parasitic effects of nitric oxide.","journal-title":"IUBMB Life"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.freeradbiomed.2004.02.008","volume":"36","author":"Comini M.A.","year":"2004","unstructured":"Comini MA, Guerrero SA, Haile S, Menge U, L\u00fcnsdorf H, Floh\u00e9 L. Valdiation of trypanothione synthetase as drug target.","journal-title":"Free Radic Biol Med"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ijpara.2009.05.010","volume":"39","author":"Piacenza L.","year":"2009","unstructured":"Piacenza L, Zago MP, Peluffo G, Alvarez MN, Basombrio MA, Radi R. Enzymes of the antioxidant network as novel determiners of virulence.","journal-title":"Int J Parasitol"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"W174","DOI":"10.1093\/nar\/gkv342","volume":"43","author":"Yang J.","year":"2015","unstructured":"Yang J, Zhang Y. I-TASSER server: New development for protein structure and function predictions.","journal-title":"Nucleic Acids Res"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"W471","DOI":"10.1093\/nar\/gks372","volume":"40","author":"Roy A.","year":"2012","unstructured":"Roy A, Yang J, Zhang Y. COFACTOR: An accurate comparative algorithm for structure-based protein function annotation.","journal-title":"Nucleic Acids Res"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF00228148","volume":"8","author":"Laskowski R.A.","year":"1996","unstructured":"Laskowski RA, Rullmann JAC, McArthur MW, Kaptein R, Thornton JM. AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR.","journal-title":"J Biomol NMR"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1093\/nar\/22.22.4673","volume":"22","author":"Thompson J.D.","year":"1994","unstructured":"Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.","journal-title":"Nucleic Acids Res"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"Oleg Trott A.J.O.","year":"2010","unstructured":"Oleg Trott AJO, Schroer A. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.","journal-title":"J Comput Chem"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10822-010-9395-8","volume":"25","author":"Lill M.A.","year":"2011","unstructured":"Lill MA, Danielson ML. Computer-aided drug design platform using PyMOL.","journal-title":"J Comput Aided Mol Des"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","volume":"19","author":"Croft S.L.","year":"2006","unstructured":"Croft SL, Sundar S, Fairlamb AH. Drug resistance in leishmaniasis.","journal-title":"Clin Microbiol Rev"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"36137","DOI":"10.1074\/jbc.M109.045336","volume":"284","author":"Torrie L.S.","year":"2009","unstructured":"Torrie LS, Wyllie S, Spinks D, Oza SL, Thompson S, Harrison JR, Gilbert IH, Wyatt PG, Fairlamb AH, Frearson JA. Chemical validation of trypanothione synthetase: A potential drug target for human trypanosomiasis.","journal-title":"J Biol Chem"}],"container-title":["Protein &amp; Peptide Letters"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/170346","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T10:18:06Z","timestamp":1721038686000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/170346\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,29]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5,29]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929866526666190301114012","relation":{},"ISSN":["0929-8665"],"issn-type":[{"value":"0929-8665","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,29]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-11-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}